New Compound Blocks 'Gatekeeper' Enzyme to Kill Malaria (VIDEO)
Caption
Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival. The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs. Read more: http://www.wehi.edu.au/site/latest_news/new_compound_blocks_gatekeeper_enzyme_to_kill_malaria
Credit
Walter and Eliza Hall Institute
Usage Restrictions
None
License
Licensed content